Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001555280-25-000203
Filing Date
2025-05-06
Accepted
2025-05-06 13:29:54
Documents
92
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zts-20250331.htm   iXBRL 10-Q 1621389
2 EX-31.1 a10qex311q12025.htm EX-31.1 8942
3 EX-31.2 a10qex312q12025.htm EX-31.2 9052
4 EX-32.1 a10qex321q12025.htm EX-32.1 4167
5 EX-32.2 a10qex322q12025.htm EX-32.2 4132
  Complete submission text file 0001555280-25-000203.txt   8578236

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zts-20250331.xsd EX-101.SCH 53300
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zts-20250331_cal.xml EX-101.CAL 72274
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zts-20250331_def.xml EX-101.DEF 280418
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zts-20250331_lab.xml EX-101.LAB 679402
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zts-20250331_pre.xml EX-101.PRE 508054
95 EXTRACTED XBRL INSTANCE DOCUMENT zts-20250331_htm.xml XML 1323929
Mailing Address 10 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 10 SYLVAN WAY PARSIPPANY NJ 07054 973-822-7000
Zoetis Inc. (Filer) CIK: 0001555280 (see all company filings)

EIN.: 460696167 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35797 | Film No.: 25916463
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)